Hindustan Unilever

Q1 FY27 (June quarter): underlying sales growth of 10% — equal parts volume and price — the best in 13 quarters. Home Care grew 14% (its best in three years), Beauty & Wellbeing 12%, Foods 7%, while Personal Care grew a slower 4%, largely price-led because of palm oil inflation. EBITDA margin held at 23%, inside management's guided 22.5-23.5% band, even as gross margin fell ~80 basis points on input costs. Reported PAT came in near flat to slightly down (~2-3% YoY) purely because Q1 FY26 contained a one-off tax credit — profit before exceptional items actually grew ~9% YoY, so the headline decline is a base-year distortion, not a real deterioration. Separately, HUL's FY26 full-year net income is reported around Rs 15,059 crore with a dividend payout ratio over 100%, both of which look inflated versus its normal run-rate of roughly Rs 2,600-3,000 crore PAT per quarter — likely reflects a one-off gain tied to the ice-cream demerger. Not verified - check on Screener for the exact exceptional-item breakdown.

Different trackers show meaningfully different P/E numbers for HUL — one shows 28.9x against a peer median of 35.61x, another shows 35.97x against an industry average of 41.09x. Setting aside the lower outlier, the cluster suggests HUL trades below its FMCG peer group and well below its own historical range (HUL has traditionally commanded 50x+ in strong growth years). Why it looks cheaper: slower sales growth and margin pressure from input costs have compressed the multiple the market is willing to pay, not a sudden re-rating of the underlying business. Whether it is actually cheap is less clear — ROE of 21.9% is well below its 10-year median of ~29.6%, so the de-rating partly tracks a genuine decline in return on equity, not just sentiment.

Growth is reviving but is mixed in character. Home Care (+14% USG) and Beauty & Wellbeing (+12% USG) are genuinely volume-led this quarter, while Personal Care's slower 4% USG is mostly price-led, driven by palm oil cost pass-through rather than higher volumes. Overall Q1 FY27 USG of 10% was split evenly between volume and price, which is a healthier mix than a purely price-driven quarter, but it is one quarter after a stretch of weak growth — too early to call it a durable trend.

HUL is close to net-cash: reported net debt of around -Rs 4,428 crore (i.e., more cash than debt), with FY26 free cash flow of about Rs 9,667 crore. ROCE is strong at roughly 29%, well above typical industry benchmarks, meaning profits are converting into cash reliably. The real risk here is business risk — input cost inflation (palm oil) and uneven urban demand — not financial or balance-sheet risk.

Promoter Unilever plc holds 61.9% of HUL, unchanged over the last year, with zero shares pledged — no leverage or governance red flag at the promoter level. Foreign institutional investors (FIIs) have trimmed their stake from 10.1% to 9.5% over the last year, while domestic mutual funds have added, rising from 6.6% to 7.15% — domestic money is partly absorbing what foreign money is selling. No marquee individual investor (the kind tracked on shareholding pages for smaller-cap stocks) shows up on HUL's register in the searches done; this is a standard institution-and-promoter-held large-cap, not a story stock.